Skip to main content

PRAXBIND 50 mg /Ml Injectable Solution For Infusion

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

Doctor
5.0(38)

Andrei Popov

General medicinePain medicine7 years of experience

Dr. Andrei Popov is a General Practitioner with specialized training in chronic pain. He provides online consultations for adult patients in Spain and other European countries.

Dr. Popov understands that seeking help with weight-related concerns or pain that has persisted for months can be difficult. Many patients come to him after trying different approaches without feeling truly heard. During the consultation, the doctor creates a comfortable and supportive, non-judgmental environment where the patient’s medical history can be discussed in detail, questions can be answered, and the next steps can be decided together.

Weight Management and Metabolic Health

Dr. Popov can help assess overweight, obesity, and related conditions such as hypertension, diabetes, or metabolic disorders. During the consultation, the patient’s medical history, test results, current medications, and previous treatments will be reviewed.

If you would like to learn about possible medication options or have already started treatment, the doctor can assess your situation, review the effectiveness and tolerability of the therapy, and clearly explain its benefits, potential risks, and alternatives.

Not every patient requires the same treatment. A consultation does not guarantee a prescription — it provides an objective medical assessment and a plan tailored to your individual situation.

Pain and General Medicine

You can also consult Dr. Popov regarding:

* chronic pain, migraines, neuralgia, and fibromyalgia;

* back, neck, lower back, or joint pain;

* hypertension, diabetes, and follow-up of chronic conditions;

* review of test results, medical reports, and current treatment;

* preventive medicine and a second medical opinion.

How the Consultation Works

The video consultation lasts up to 30 minutes. The doctor will listen carefully, review the information you provide, and explain the next steps in clear and understandable language.

If additional tests, an in-person consultation, or urgent medical care are required, the doctor will inform you directly.

Dr. Popov’s goal is to make sure the patient feels heard and leaves the consultation with a clear understanding of their condition and the next steps they can take.

Book a video appointment
€86
This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use PRAXBIND 2.5 G/50 ML INJECTABLE SOLUTION FOR INFUSION

Contents of the leaflet

  1. Introduction
  2. What is Praxbind and what is it used for
  3. What you need to know before you are given Praxbind
  4. How Praxbind is given
  5. Possible Side Effects
  6. Storage of Praxbind
  7. Contents of the Pack and Other Information

Introduction

Package Leaflet: Information for the Patient and User

Praxbind 2.5g/50ml Solution for Injection and Infusion

idarucizumab

Read all of this leaflet carefully, because it contains important information for you. Note that this medicine is used mainly in emergency situations where your doctor has decided that you need it.

  • Keep this leaflet, as you may need to read it again.
  • If you have any further questions, ask your doctor or nurse.
  • If you experience any side effects, talk to your doctor or nurse, even if they are not listed in this leaflet. See section 4.

Contents of the Package Leaflet

  1. What is Praxbind and what is it used for
  2. What you need to know before you are given Praxbind
  3. How Praxbind is given
  4. Possible side effects
  5. Storage of Praxbind
  6. Contents of the pack and other information

1. What is Praxbind and what is it used for

What is Praxbind

Praxbind contains the active substance idarucizumab. Idarucizumab is a specific reversal agent for dabigatran, a medicine that thins the blood and blocks a substance in the body that is involved in the formation of blood clots.

Praxbind is used to quickly capture dabigatran in order to neutralize its effect.

What Praxbind is used for

Praxbind is used in adults in emergency situations when your doctor decides that it is necessary to quickly neutralize the effect of dabigatran:

  • For emergency surgical interventions or urgent procedures.
  • In cases of potentially life-threatening or uncontrolled bleeding.
Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you are given Praxbind

Warnings and Precautions

Tell your doctor or nurse before you are given Praxbind:

  • if you are allergic to idarucizumab or any of the other ingredients included in section 6.
  • if you have a genetic disorder called hereditary fructose intolerance. In this case, the sorbitol contained in this medicine may cause serious adverse reactions.

These professionals will take these factors into account before treating you with Praxbind.

This medicine only removes dabigatran from your body. It does not remove other medicines used to prevent blood clot formation.

After dabigatran has been removed from your body, you will not be protected against blood clot formation. Your doctor will continue to treat you with medicines used to prevent blood clot formation as soon as your medical situation allows it.

Children and Adolescents

There is no information on the use of Praxbind in children.

Other Medicines and Praxbind

Tell your doctor if you are taking, have recently taken, or might take any other medicines.

This medicine has been developed to bind only to dabigatran. It is unlikely that Praxbind will interfere with the effect of other medicines, or that other medicines will interfere with Praxbind.

Pregnancy and Breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor before receiving this medicine.

There is no information on the effects of this medicine in pregnant or breastfeeding women. Praxbind does not affect any function in the body as such, so your doctor may decide to administer this medicine if the expected benefits outweigh the potential risks.

Praxbind contains Sodium

This medicine contains 50 mg of sodium (main component of table/cooking salt) per dose. This is equivalent to 2.5% of the maximum recommended daily intake of sodium for an adult.

3. How Praxbind is given

This medicine is for hospital use only.

The recommended dose is 5 g (2 vials of 2.5 g/50 ml).

In rare cases, you may still have too much dabigatran in your blood after a first dose of this medicine, and your doctor may decide to administer a second dose of 5 g in specific situations.

Your doctor or nurse will administer this medicine by injection or infusion into a vein.

After receiving this medicine, your doctor will decide whether you should continue treatment to prevent blood clot formation. Dabigatran can be administered again 24 hours after administration of this medicine.

At the end of this leaflet, detailed instructions for the doctor or nurse on how to administer this medicine are included (see "Handling Instructions").

If you have any further questions about the use of this medicine, ask your doctor.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible Side Effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

So far, no side effects have been identified.

Reporting of Side Effects

If you experience any side effects, talk to your doctor or nurse, even if they are not listed in this leaflet. You can also report side effects directly via the national reporting system included in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Praxbind

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date stated on the vial and carton after "EXP". The expiry date is the last day of the month stated.

Store in a refrigerator (between 2°C and 8°C).

Do not freeze.

Store in the original packaging to protect from light.

Once opened, this medicine is for immediate use.

6. Contents of the Pack and Other Information

Composition of Praxbind

  • The active substance is idarucizumab.
  • The other ingredients are: sodium acetate trihydrate (E262), acetic acid (E260, for pH adjustment), sorbitol (E420), polysorbate 20 (E432), and water for injections.

Appearance and Pack Contents

Praxbind is a clear to slightly opalescent and colorless to slightly yellow solution supplied in a glass vial closed with a butyl rubber stopper and an aluminum cap.

Each pack contains two vials.

Marketing Authorisation Holder

Boehringer Ingelheim International GmbH

Binger Str. 173

55216 Ingelheim am Rhein

Germany

Manufacturer

Boehringer Ingelheim Pharma GmbH & Co. KG

Birkendorfer Strasse 65

88397 Biberach an der Riss

Germany

Boehringer Ingelheim France

100-104 Avenue de France

75013 Paris

France

You can request more information about this medicine from the local representative of the marketing authorisation holder:

België/Belgique/Belgien

Boehringer Ingelheim SCommTél/Tel: +32 2 773 33 11

Lietuva

Boehringer Ingelheim RCV GmbH & Co KG

Lietuvos filialas

Tel: +370 5 2595942

Text in Bulgarian language with company name, address, and phone number for contact

Luxembourg/Luxemburg

Boehringer Ingelheim SCommTél/Tel: +32 2 773 33 11

Ceská republika

Boehringer Ingelheim spol. s r.o.

Tel: +420 234 655 111

Magyarország

Boehringer Ingelheim RCV GmbH & Co KG Magyarországi Fióktelepe

Tel: +36 1 299 89 00

Danmark

Boehringer Ingelheim Danmark A/S

Tlf: +45 39 15 88 88

Malta

Boehringer Ingelheim Ireland Ltd.

Tel: +353 1 295 9620

Deutschland

Boehringer Ingelheim Pharma GmbH & Co. KG

Tel: +49 (0) 800 77 90 900

Nederland

Boehringer Ingelheim B.V.

Tel: +31 (0) 800 22 55 889

Eesti

Boehringer Ingelheim RCV GmbH & Co KG

Eesti filiaal

Tel: +372 612 8000

Norge

Boehringer Ingelheim Danmark

Norwegian branch

Tlf: +47 66 76 13 00

Ελλ?δα

Boehringer Ingelheim Ελλ?ς Μονοπρ?σωπη A.E.

Tηλ: +30 2 10 89 06 300

Österreich

Boehringer Ingelheim RCV GmbH & Co KG

Tel: +43 1 80 105‑7870

España

Boehringer Ingelheim España, S.A.

Tel: +34 93 404 51 00

Polska

Boehringer Ingelheim Sp. z o.o.

Tel: +48 22 699 0 699

France

Boehringer Ingelheim France S.A.S.

Tél: +33 3 26 50 45 33

Portugal

Boehringer Ingelheim Portugal, Lda.

Tel: +351 21 313 53 00

Hrvatska

Boehringer Ingelheim Zagreb d.o.o.

Tel: +385 1 2444 600

România

Boehringer Ingelheim RCV GmbH & Co KG Viena ‑ Sucursala Bucuresti

Tel: +40 21 302 28 00

Ireland

Boehringer Ingelheim Ireland Ltd.

Tel: +353 1 295 9620

Slovenija

Boehringer Ingelheim RCV GmbH & Co KG Podružnica Ljubljana

Tel: +386 1 586 40 00

Ísland

Vistor ehf.

Sími: +354 535 7000

Slovenská republika

Boehringer Ingelheim RCV GmbH & Co KG organizacná zložka

Tel: +421 2 5810 1211

Italia

Boehringer Ingelheim Italia S.p.A.

Tel: +39 02 5355 1

Suomi/Finland

Boehringer Ingelheim Finland Ky

Puh/Tel: +358 10 3102 800

Κ?προς

Boehringer Ingelheim Ελλ?ς Μονοπρ?σωπη A.E.

Tηλ: +30 2 10 89 06 300

Sverige

Boehringer Ingelheim AB

Tel: +46 8 721 21 00

Latvija

Boehringer Ingelheim RCV GmbH & Co KG

Latvijas filiale

Tel: +371 67 240 011

United Kingdom(Northern Ireland)

Boehringer Ingelheim Ireland Ltd.

Tel: +353 1 295 9620

Date of Last Revision of this Leaflet:

Other Sources of Information

Detailed information on this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu.

-------------------------------------------------------------------------------------------------------------------

This information is intended only for healthcare professionals:

Praxbind specifically binds to dabigatran and reverses its anticoagulant effect. It does not reverse the effects of other anticoagulants.

Treatment with Praxbind may be used in combination with other standard supportive measures, if these are deemed medically appropriate.

In order to improve the traceability of biological medicinal products, the name and batch number of the administered product should be clearly recorded.

The recommended dose of Praxbind contains 4 g of sorbitol as an excipient. In patients with hereditary fructose intolerance, there is a risk of serious adverse reactions, which should be weighed against the benefit of emergency treatment with Praxbind. If Praxbind is administered to these patients, medical supervision should be intensified during exposure to Praxbind and within 24 hours after exposure to Praxbind.

Posology and Method of Administration:

The recommended dose is 5 g of idarucizumab (2 vials of 2.5 g/50 ml).

A second dose of 5 g of idarucizumab may be considered in the following situations:

  • recurrence of clinically relevant bleeding together with prolonged coagulation times, or
  • if a potential new bleed would be life-threatening and prolonged coagulation times are observed, or
  • patients require a second emergency surgical intervention or urgent procedure and have prolonged coagulation times.

The main parameters of coagulation are activated partial thromboplastin time (aPTT), diluted thrombin time (dTT), or ecarin clotting time (ECT).

No maximum daily dose has been investigated.

Praxbind (2 vials of 2.5 g/50 ml) is administered intravenously in two consecutive infusions of 5 to 10 minutes each or as a rapid injection (bolus).

Patients receiving dabigatran treatment have underlying diseases that predispose them to thromboembolic events. Reversal of dabigatran treatment exposes patients to the risk of thrombosis derived from their underlying disease. To reduce this risk, resumption of anticoagulant treatment should be considered as soon as medically appropriate.

Treatment with dabigatran etexilate may be restarted 24 hours after administration of idarucizumab, provided the patient is clinically stable and adequate hemostasis has been achieved.

After administration of idarucizumab, another antithrombotic treatment (e.g., with low molecular weight heparin) may be initiated at any time, provided the patient is clinically stable and adequate hemostasis has been achieved.

Handling Instructions:

Praxbind must not be mixed with other medicines. For administration of Praxbind, a pre-existing intravenous line may be used. This line should be flushed with a 9 mg/ml sodium chloride solution (0.9%) before and after infusion. No other infusion should be administered in parallel through the same intravenous access.

Praxbind is for single use and does not contain preservatives.

Before use, the unopened vial may be stored at room temperature (up to 30°C) for up to 48 hours, if kept in the original packaging to protect from light. After opening the vial, the chemical and physical stability of idarucizumab has been demonstrated for 6 hours at room temperature (up to 30°C). The solution should not be exposed to light for more than 6 hours (in the unopened vial and/or in use).

From a microbiological point of view, unless the method of opening precludes the risk of microbial contamination, the product should be used immediately after opening. If not used immediately, the in-use storage times and conditions are the responsibility of the user.

No incompatibilities have been observed between Praxbind and infusion equipment made of polyvinyl chloride, polyethylene, or polyurethane, or with polypropylene syringes.

Online doctors for PRAXBIND 2.5 G/50 ML INJECTABLE SOLUTION FOR INFUSION

Discuss questions about PRAXBIND 2.5 G/50 ML INJECTABLE SOLUTION FOR INFUSION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

Doctor
5.0(38)

Andrei Popov

General medicinePain medicine7 years of experience

Dr. Andrei Popov is a General Practitioner with specialized training in chronic pain. He provides online consultations for adult patients in Spain and other European countries.

Dr. Popov understands that seeking help with weight-related concerns or pain that has persisted for months can be difficult. Many patients come to him after trying different approaches without feeling truly heard. During the consultation, the doctor creates a comfortable and supportive, non-judgmental environment where the patient’s medical history can be discussed in detail, questions can be answered, and the next steps can be decided together.

Weight Management and Metabolic Health

Dr. Popov can help assess overweight, obesity, and related conditions such as hypertension, diabetes, or metabolic disorders. During the consultation, the patient’s medical history, test results, current medications, and previous treatments will be reviewed.

If you would like to learn about possible medication options or have already started treatment, the doctor can assess your situation, review the effectiveness and tolerability of the therapy, and clearly explain its benefits, potential risks, and alternatives.

Not every patient requires the same treatment. A consultation does not guarantee a prescription — it provides an objective medical assessment and a plan tailored to your individual situation.

Pain and General Medicine

You can also consult Dr. Popov regarding:

* chronic pain, migraines, neuralgia, and fibromyalgia;

* back, neck, lower back, or joint pain;

* hypertension, diabetes, and follow-up of chronic conditions;

* review of test results, medical reports, and current treatment;

* preventive medicine and a second medical opinion.

How the Consultation Works

The video consultation lasts up to 30 minutes. The doctor will listen carefully, review the information you provide, and explain the next steps in clear and understandable language.

If additional tests, an in-person consultation, or urgent medical care are required, the doctor will inform you directly.

Dr. Popov’s goal is to make sure the patient feels heard and leaves the consultation with a clear understanding of their condition and the next steps they can take.

Book a video appointment
€86
Doctor
5.0(12)

Yevgen Yakovenko

General medicine12 years of experience

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise:

  • Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan.
  • Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions.
  • Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies.
  • General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries.
  • Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required.
  • Oncological surgery: diagnosis review, treatment planning, and long-term follow-up.
  • Obesity treatment and weight management: a medical approach to weight loss, including assessment of underlying causes, evaluation of comorbidities, development of a personalised plan (nutrition, physical activity, pharmacotherapy if needed), and ongoing progress monitoring.
  • Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data.
  • Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications:

  • 12+ years of clinical experience in university hospitals in Germany and Spain.
  • International education: Ukraine – Germany – Spain.
  • Member of the German Society of Surgeons (BDC).
  • Certified in radiological diagnostics and robotic surgery.
  • Active participant in international medical conferences and research.

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

Book a video appointment
€72
Doctor
5.0(3)

Lina Travkina

General medicine13 years of experience

Dr. Lina Travkina is a licensed family and preventive medicine doctor based in Italy. She provides online consultations for adults and children, supporting patients across all stages of care – from acute symptom management to long-term health monitoring and prevention.Areas of medical care include:

  • Respiratory conditions: colds, flu, acute and chronic bronchitis, mild to moderate pneumonia, bronchial asthma.

  • ENT and eye conditions: sinusitis, tonsillitis, pharyngitis, otitis, infectious and allergic conjunctivitis.

  • Digestive issues: gastritis, acid reflux (GERD), IBS, dyspepsia, bloating, constipation, diarrhoea, functional bowel symptoms, intestinal infections.

  • Urological and infectious diseases: acute and recurrent cystitis, bladder and kidney infections, prevention of recurrent UTIs, asymptomatic bacteriuria.

  • Chronic conditions: hypertension, diabetes, hypercholesterolemia, metabolic syndrome, thyroid disorders, excess weight.

  • Neurological and general symptoms: headache, migraine, dizziness, fatigue, sleep disturbances, reduced concentration, anxiety, asthenia.

  • Chronic pain support: back, neck, joint, and muscle pain, tension syndromes, pain associated with osteochondrosis and chronic conditions.

Additional care areas:

  • Preventive consultations and check-up planning.

  • Medical advice and follow-up consultations.

  • Test interpretation and diagnostic guidance.

  • Structured support for undiagnosed complaints.

  • Second opinion on diagnoses and treatment plans.

  • Nutritional and lifestyle support for vitamin deficiencies, anaemia, metabolic issues.

  • Post-operative recovery support and pain management.

  • Preconception counselling and postpartum support.

  • Immunity support and strategies to reduce frequency of infections.

Dr. Travkina combines evidence-based medicine with an attentive, personalised approach. Her consultations focus not only on treatment, but also on prevention, recovery, and long-term wellbeing.If during the consultation it becomes clear that your case requires in-person assessment or specialised care outside of her scope, the session will be terminated and the payment fully refunded.

Book a video appointment
€75
Doctor
5.0(20)

Nuno Tavares Lopes

General medicine18 years of experience

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies

  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management

  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses

  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment

  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance

  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis

  • Pain management: acute and chronic pain, post-surgical care

  • Public health: prevention, health screenings, long-term monitoring

  • Sick leave (Baixa médica) connected to Segurança Social in Portugal

  • IMT medical certificates for driving licence exchange

Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Book a video appointment
€70
Doctor
0.0(0)

Hocine Lokchiri

General medicine21 years of experience

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
Book a video appointment
€64

Get PRAXBIND 2.5 G/50 ML INJECTABLE SOLUTION FOR INFUSION Prescription Online

1

Fill in a 2-min form

Tell us your symptoms, history, and what medicine you're requesting.

2

Pick a doctor or let us assign

Choose a specialist or we'll match you with the next available doctor.

3

Doctor reviews your case

Usually within 30 minutes. They may ask follow-up questions via chat.

4

Collect from any pharmacy

Electronic prescription sent to your email — valid across Spain.

Frequently Asked Questions

PRAXBIND 2.5 G/50 ML INJECTABLE SOLUTION FOR INFUSION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.

The active ingredient in PRAXBIND 2.5 G/50 ML INJECTABLE SOLUTION FOR INFUSION is idarucizumab. This information helps identify medicines with the same composition but different brand names.

PRAXBIND 2.5 G/50 ML INJECTABLE SOLUTION FOR INFUSION is manufactured by Boehringer Ingelheim International Gmbh. Pharmacy brands and packaging may differ depending on the distributor.

Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether PRAXBIND 2.5 G/50 ML INJECTABLE SOLUTION FOR INFUSION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.

Spain has a well-developed healthcare infrastructure across major cities such as Madrid, Barcelona, Valencia, and Seville. Pharmacies are widely available and operate under strict regulations, ensuring access to prescribed medications.

You can buy PRAXBIND 2.5 G/50 ML INJECTABLE SOLUTION FOR INFUSION in Madrid, Barcelona, Seville, or Valencia at any local pharmacy with a valid prescription.

To obtain a prescription, you can use Oladoctor:

Other medicines with the same active substance (idarucizumab) include ANEXATE 0.5 mg/5 ml INJECTABLE SOLUTION, ANEXATE 1 mg/10 ml INJECTABLE SOLUTION, BRIDION 100 mg/mL INJECTABLE SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media